In HNSCC the action of MK2 is thought to enhance proliferation and metastasis through long coding mRNA [13], transcript stability [14] and cross talk of genes such as IGFBP2, MUC2 and PRKAR3B [15]. The gene discussed is MAPKAPK2; the disease is head and neck squamous cell carcinoma.